Hepatitis B
-
The Erosion of the Pediatric Vaccine Firewall: Hepatitis B Policy and FDA Turmoil
The rollback of universal hepatitis B birth-dose vaccine recommendations, coupled with high-level turnover at the FDA, signals a profound shift in American public health policy, raising concerns over long-term infant mortality and the integrity of federal health institutions.
-
CDC Panel Sparks Controversy by Recommending Individual Choice for Newborn Hepatitis B Vaccine
In a dramatic shift, the CDC’s vaccine advisory panel has voted to end universal hepatitis B vaccination for newborns, recommending that families consult with healthcare providers instead—a decision that has ignited fierce debate among medical experts, pediatricians, and public health…